Suppr超能文献

与促甲状腺激素释放激素(TRH)阴性试验相比,促甲状腺激素(TSH)基础浓度降低在甲状腺功能亢进症检测与排除中的诊断相关性。

Diagnostic relevance of suppressed basal concentrations of TSH compared with the negative TRH test in detection and exclusion of hyperthyroidism.

作者信息

Roden M, Nowotny P, Vierhapper H, Waldhäusl W

机构信息

I. Department of Internal Medicine, University of Vienna, Austria.

出版信息

Acta Endocrinol (Copenh). 1991 Feb;124(2):136-42. doi: 10.1530/acta.0.1240136.

Abstract

To evaluate the sensitivity of basal TSH concentrations as determined by an "ultrasensitive" IRMA-assay (RIA-gnost h-TSH-monoclonal, Behring) versus a "negative" TRH test (defined as an increment of TSH less than or equal to 0.2 mU/l 20 min after administration of 400 micrograms TRH iv) in the diagnosis of hyperthyroidism we examined 193 consecutive patients from our thyroid outpatient clinic: 34 patients displayed hyperthyroidism (total T4: 184.4 +/- 26.0 mumol/l, effective thyroxine index: 1.25 +/- 0.08), whereas 12 had isolated T3-hyperthyroidism (total T3: 3.47 +/- 0.48 nmol/l). Employing the producer's definition of subnormal ("suppressed") bTSH concentrations (less than or equal to 0.1 mU/l), only 19 (41.3%) hyperthyroid patients would have been detected; on the other hand, one euthyroid patient would have been recognized false positively as hyperthyroid. Using the TRH test as criterion led to the correct diagnosis in 42 (sensitivity: 91.3%) hyperthyroid patients, whereas two had low bTSH concentrations (less than or equal to 0.5 mU/l), but a normal TSH response to TRH (greater than 2.0 mU/l). Raising the threshold concentration to 0.2 and, subsequently, to 0.4 mU TSH/l increased the number of correct results to 38 (sensitivity: 82.6%) and 43 (93.5%), respectively. This was associated with a concomitant decrease in specificity in the diagnosis of hyperthyroidism from 93.7 (0.1 mU/l) to 27.9% (0.4 mU/l). In conclusion, despite ultrasensitive methods for estimation of low TSH concentrations, the TRH test remains an irreplaceable tool for the correct diagnosis of hyperthyroidism.

摘要

为评估采用“超敏”免疫放射测定法(RIA-gnost h-TSH-单克隆,贝林公司)测定的基础促甲状腺激素(TSH)浓度与“阴性”促甲状腺激素释放激素(TRH)试验(定义为静脉注射400微克TRH后20分钟TSH升高幅度小于或等于0.2 mU/l)在诊断甲状腺功能亢进症中的敏感性,我们检查了来自甲状腺门诊的193例连续患者:34例患者表现为甲状腺功能亢进症(总T4:184.4±26.0 μmol/l,有效甲状腺素指数:1.25±0.08),而12例为单纯T3型甲状腺功能亢进症(总T3:3.47±0.48 nmol/l)。采用生产商定义的低于正常(“受抑制”)的基础TSH浓度(小于或等于0.1 mU/l),仅能检测出19例(41.3%)甲状腺功能亢进症患者;另一方面,1例甲状腺功能正常的患者会被误诊为甲状腺功能亢进症。以TRH试验为标准,42例(敏感性:91.3%)甲状腺功能亢进症患者得到正确诊断,而2例基础TSH浓度较低(小于或等于0.5 mU/l),但对TRH的TSH反应正常(大于2.0 mU/l)。将阈值浓度提高到0.2 mU/l,随后提高到0.4 mU/l时,正确结果的数量分别增加到38例(敏感性:82.6%)和43例(93.5%)。这伴随着甲状腺功能亢进症诊断特异性从93.7%(0.1 mU/l时)降至27.9%(0.4 mU/l时)。总之,尽管有超敏方法用于估计低TSH浓度,但TRH试验仍是正确诊断甲状腺功能亢进症不可替代的工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验